President Donald Trump said his executive order on drug prices would lower some prices in half or more. But the details are ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

From sweeping drug price reforms to proposed staffing mandates and changes to Medicaid financing, here are five federal policy moves from the last week that ASCs need to know: CMS proposes updates for ...

What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or ...

President Donald Trump put the pharmaceutical industry on notice early Monday with the signing of his "most favored nation" ...

This month, the Centers for Medicare and Medicaid Services will begin meeting with patients who use the 15 drugs it selected ...

For decades, Americans have been overpaying for prescriptions and subsidizing innovation for the rest of the world. The White ...

Pharmacy benefit managers face new compensation restrictions and transparency rules from the sweeping reconciliation budget ...

Americans spend more on prescription and over-the-counter drugs than anyone else in the world. It’s true that they take a lot ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...